Simplex Trading’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$190K Buy
+2,916
New +$201K ﹤0.01% 4686
2025
Q2
– Sell
-627
Closed -$27K – 9889
2025
Q1
$27K Buy
+627
New +$27.7K ﹤0.01% 6346
2024
Q4
– Sell
-39
Closed -$1K – 9791
2024
Q3
$1K Buy
+39
New +$1.67K ﹤0.01% 8309
2024
Q1
– Sell
-910
Closed -$37K – 10068
2023
Q4
$37K Buy
+910
New +$34.5K ﹤0.01% 6382
2023
Q1
– Sell
-10
Closed – – 10293
2022
Q4
$0 Buy
+10
New +$416 ﹤0.01% 10620
2021
Q4
– Sell
-1,350
Closed -$70K – 11609
2021
Q3
$70K Hold
1,350
– – ﹤0.01% 7093
2021
Q2
$69K Sell
1,350
-71
-5% -$3.56K ﹤0.01% 7240
2021
Q1
$71K Buy
1,421
+1,292
+1,002% +$68.9K ﹤0.01% 6195
2020
Q4
$6K Sell
129
-1,862
-94% -$89K ﹤0.01% 7675
2020
Q3
$86K Buy
1,991
+1,891
+1,891% +$82.8K ﹤0.01% 5059
2020
Q2
$4K Buy
100
+67
+203% +$2.77K ﹤0.01% 7083
2020
Q1
$1K Buy
+33
New +$1.41K ﹤0.01% 7424
2019
Q1
– Sell
-96
Closed -$3K – 7987
2018
Q4
$3K Buy
+96
New +$4.1K ﹤0.01% 6474
2017
Q1
– Sell
-100
Closed -$3K – 6880
2016
Q4
$3K Buy
+100
New +$4.07K ﹤0.01% 4840

Other funds holding XPH

Simplex Trading's XPH Position: Q3 2026 in Review

Simplex Trading opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2026: 2,916 shares worth $190K. The stake represents ﹤0.01% of the portfolio and ranks #4686 among its holdings. This is a return to the name: Simplex Trading previously reported a position in XPH as recently as Q1 2025.

Simplex Trading first reported a position in XPH in Q4 2016 and has held it in 14 quarters since. 96 funds tracked by Wall St. Rank hold XPH as of Q3 2026.

  • Simplex Trading held 2,916 shares of State Street SPDR S&P Pharmaceuticals ETF worth $190K as of Q3 2026.
  • State Street SPDR S&P Pharmaceuticals ETF was a new Simplex Trading position in Q3 2026.
  • State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #4686 holding.
  • Simplex Trading first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2016 and has held it in 14 quarters since.
  • 96 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.